Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development (original) (raw)
References
Ascenzi P, Bocdi A, Bolognesi M, Spallarose A, Colletta M, De Cristofaro R et al. (2003). The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr Protein Pept Sci4: 231–251. ArticleCAS Google Scholar
Fan B, Wu TD, Li W, Kirchhofer D . (2005). Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem280: 34513–34520. ArticleCAS Google Scholar
Gailani D, Lasky NM, Broze Jr GJ . (1997). A murine model of factor XI deficiency. Blood Coagul Fibrinolysis8: 134–144. ArticleCAS Google Scholar
Gao F, Shi HY, Daughty C, Cella N, Zhang M . (2004). Maspin plays an essential role in early embryonic development. Development131: 1479–1489. ArticleCAS Google Scholar
Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P et al. (2005). Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J390: 125–136. ArticleCAS Google Scholar
Hooper JD, Campagnolo L, Goodarzi G, Truong TN, Stuhlmann H, Quigley JP . (2003). Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem J373: 689–702. ArticleCAS Google Scholar
Huang ZF, Higuchi D, Lasky N, Broze Jr GJ . (1997). Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood90: 944–951. CASPubMed Google Scholar
Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M et al. (2000). Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest106: 873–878. ArticleCAS Google Scholar
Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T et al. (2004). Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology127: 1423–1435. ArticleCAS Google Scholar
Kaufmann MH, Bart S . (1999). The Anatomical Basis of Mouse Development, revised edn. Academic Press: San Diego, CA. Google Scholar
Lin CY, Anders J, Johnson M, Dickson RB . (1999). Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem274: 18237–18242. ArticleCAS Google Scholar
List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W et al. (2002). Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene21: 3765–3779. ArticleCAS Google Scholar
List K, Szabo R, Molinolo A, Nielsen BS, Bugge TH . (2006). Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am J Pathol168: 1513–1525. ArticleCAS Google Scholar
List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T et al. (2005). Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev19: 1934–1950. ArticleCAS Google Scholar
Oberst MD, Chen LY, Kiyomiya K, Williams CA, Lee MS, Johnson MD et al. (2005). HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol289: C462–C470. ArticleCAS Google Scholar
Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY . (2003a). Characterization of matriptase expression in normal human tissues. J Histochem Cytochem51: 1017–1025. ArticleCAS Google Scholar
Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY . (2003b). The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem278: 26773–26779. ArticleCAS Google Scholar
Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM et al. (2001). The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell107: 789–800. ArticleCAS Google Scholar
Ohmuraya M, Hirota M, Araki M, Mizushima N, Matsui M, Mizumoto T et al. (2005). Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology129: 696–705. ArticleCAS Google Scholar
Riley P, Anson-Cartwright L, Cross JC . (1998). The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet18: 271–275. ArticleCAS Google Scholar
Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J et al. (1997). Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem272: 6370–6376. ArticleCAS Google Scholar
Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM, Bugge TH . (2005). Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem J390: 231–242. ArticleCAS Google Scholar
Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T et al. (2005). Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol25: 5687–5698. ArticleCAS Google Scholar
Velasco G, Cal S, Quesada V, Sanchez LM, Lopez-Otin C . (2002). Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem30: 37637–37646. Article Google Scholar
Wu Q, Yu D, Post J, Halks-Miller M, Sadler JE, Morser J . (1998). Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest101: 321–326. ArticleCAS Google Scholar
Zeeuwen PL, van Vlijmen-Willems IM, Hendriks W, Merkx GF, Schalkwijk J . (2002). A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification. Hum Mol Genet11: 2867–2875. ArticleCAS Google Scholar